Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity.

Santa KumarDas; KamalRanabhat; Suraj Bhattarai ORCID logo; Khem BahadurKarki; PradipGyanwali; Hem RajPaneru; BipinNepal; Shyam PrakashDumre; Subhash PrasadAcharya; (2021) Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbidity. Clinical case reports, 9 (4). pp. 2132-2137. ISSN 2050-0904 DOI: 10.1002/ccr3.3964
Copy

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID-19 patients with obesity and chronic diseases such as diabetes and hypertension.
Item Type Article
Elements ID 195278
Official URL http://dx.doi.org/10.1002/ccr3.3964

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads

picture_as_pdf
Combination of convalescent plasma therapy and repurposed drugs to treat severe.pdf
subject
Published Version
Available under Creative Commons: 4.0
View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: